The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Antibody-drug Conjugates-Global Market Insights and Sales Trends 2025

Antibody-drug Conjugates-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1815788

No of Pages : 78

Ask Your Query

Synopsis

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

The global Antibody-drug Conjugates market size is expected to reach US$ 3919.8 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Antibody-drug Conjugates in various end use industries. The expanding demands from the Breast Cancer and Lymphoma, are propelling Antibody-drug Conjugates market. Adcetris, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Kadcyla segment is estimated at % CAGR for the next seven-year period.

North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibody-drug Conjugates, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Antibody-drug Conjugates market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Antibody-drug Conjugates market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibody-drug Conjugates sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Antibody-drug Conjugates covered in this report include ImmunoGen, Seattle Genetics, Roche and Takeda, etc.

The global Antibody-drug Conjugates market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • ImmunoGen
  • Seattle Genetics
  • Roche
  • Takeda

Global Antibody-drug Conjugates market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Antibody-drug Conjugates market, Segment by Type:

  • Adcetris
  • Kadcyla

Global Antibody-drug Conjugates market, by Application

  • Breast Cancer
  • Lymphoma

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antibody-drug Conjugates manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antibody-drug Conjugates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Antibody-drug Conjugates Market Overview
1.1 Antibody-drug Conjugates Product Overview
1.2 Antibody-drug Conjugates Market Segment by Type
1.2.1 Adcetris
1.2.2 Kadcyla
1.3 Global Antibody-drug Conjugates Market Size by Type
1.3.1 Global Antibody-drug Conjugates Market Size Overview by Type (2018-2029)
1.3.2 Global Antibody-drug Conjugates Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antibody-drug Conjugates Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antibody-drug Conjugates Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antibody-drug Conjugates Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antibody-drug Conjugates Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antibody-drug Conjugates Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antibody-drug Conjugates Sales Breakdown by Type (2018-2023)
2 Global Antibody-drug Conjugates Market Competition by Company
2.1 Global Top Players by Antibody-drug Conjugates Sales (2018-2023)
2.2 Global Top Players by Antibody-drug Conjugates Revenue (2018-2023)
2.3 Global Top Players by Antibody-drug Conjugates Price (2018-2023)
2.4 Global Top Manufacturers Antibody-drug Conjugates Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibody-drug Conjugates Market Competitive Situation and Trends
2.5.1 Antibody-drug Conjugates Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibody-drug Conjugates Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2022)
2.7 Date of Key Manufacturers Enter into Antibody-drug Conjugates Market
2.8 Key Manufacturers Antibody-drug Conjugates Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antibody-drug Conjugates Status and Outlook by Region
3.1 Global Antibody-drug Conjugates Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antibody-drug Conjugates Historic Market Size by Region
3.2.1 Global Antibody-drug Conjugates Sales in Volume by Region (2018-2023)
3.2.2 Global Antibody-drug Conjugates Sales in Value by Region (2018-2023)
3.2.3 Global Antibody-drug Conjugates Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antibody-drug Conjugates Forecasted Market Size by Region
3.3.1 Global Antibody-drug Conjugates Sales in Volume by Region (2024-2029)
3.3.2 Global Antibody-drug Conjugates Sales in Value by Region (2024-2029)
3.3.3 Global Antibody-drug Conjugates Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antibody-drug Conjugates by Application
4.1 Antibody-drug Conjugates Market Segment by Application
4.1.1 Breast Cancer
4.1.2 Lymphoma
4.2 Global Antibody-drug Conjugates Market Size by Application
4.2.1 Global Antibody-drug Conjugates Market Size Overview by Application (2018-2029)
4.2.2 Global Antibody-drug Conjugates Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antibody-drug Conjugates Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antibody-drug Conjugates Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antibody-drug Conjugates Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antibody-drug Conjugates Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antibody-drug Conjugates Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antibody-drug Conjugates Sales Breakdown by Application (2018-2023)
5 North America Antibody-drug Conjugates by Country
5.1 North America Antibody-drug Conjugates Historic Market Size by Country
5.1.1 North America Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antibody-drug Conjugates Sales in Volume by Country (2018-2023)
5.1.3 North America Antibody-drug Conjugates Sales in Value by Country (2018-2023)
5.2 North America Antibody-drug Conjugates Forecasted Market Size by Country
5.2.1 North America Antibody-drug Conjugates Sales in Volume by Country (2024-2029)
5.2.2 North America Antibody-drug Conjugates Sales in Value by Country (2024-2029)
6 Europe Antibody-drug Conjugates by Country
6.1 Europe Antibody-drug Conjugates Historic Market Size by Country
6.1.1 Europe Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antibody-drug Conjugates Sales in Volume by Country (2018-2023)
6.1.3 Europe Antibody-drug Conjugates Sales in Value by Country (2018-2023)
6.2 Europe Antibody-drug Conjugates Forecasted Market Size by Country
6.2.1 Europe Antibody-drug Conjugates Sales in Volume by Country (2024-2029)
6.2.2 Europe Antibody-drug Conjugates Sales in Value by Country (2024-2029)
7 Asia-Pacific Antibody-drug Conjugates by Region
7.1 Asia-Pacific Antibody-drug Conjugates Historic Market Size by Region
7.1.1 Asia-Pacific Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antibody-drug Conjugates Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antibody-drug Conjugates Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antibody-drug Conjugates Forecasted Market Size by Region
7.2.1 Asia-Pacific Antibody-drug Conjugates Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antibody-drug Conjugates Sales in Value by Region (2024-2029)
8 Latin America Antibody-drug Conjugates by Country
8.1 Latin America Antibody-drug Conjugates Historic Market Size by Country
8.1.1 Latin America Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antibody-drug Conjugates Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antibody-drug Conjugates Sales in Value by Country (2018-2023)
8.2 Latin America Antibody-drug Conjugates Forecasted Market Size by Country
8.2.1 Latin America Antibody-drug Conjugates Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antibody-drug Conjugates Sales in Value by Country (2024-2029)
9 Middle East and Africa Antibody-drug Conjugates by Country
9.1 Middle East and Africa Antibody-drug Conjugates Historic Market Size by Country
9.1.1 Middle East and Africa Antibody-drug Conjugates Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antibody-drug Conjugates Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antibody-drug Conjugates Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antibody-drug Conjugates Forecasted Market Size by Country
9.2.1 Middle East and Africa Antibody-drug Conjugates Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antibody-drug Conjugates Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 ImmunoGen
10.1.1 ImmunoGen Company Information
10.1.2 ImmunoGen Introduction and Business Overview
10.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
10.1.4 ImmunoGen Antibody-drug Conjugates Products Offered
10.1.5 ImmunoGen Recent Development
10.2 Seattle Genetics
10.2.1 Seattle Genetics Company Information
10.2.2 Seattle Genetics Introduction and Business Overview
10.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Seattle Genetics Antibody-drug Conjugates Products Offered
10.2.5 Seattle Genetics Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Roche Antibody-drug Conjugates Products Offered
10.3.5 Roche Recent Development
10.4 Takeda
10.4.1 Takeda Company Information
10.4.2 Takeda Introduction and Business Overview
10.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Takeda Antibody-drug Conjugates Products Offered
10.4.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody-drug Conjugates Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody-drug Conjugates Industrial Chain Analysis
11.4 Antibody-drug Conjugates Market Dynamics
11.4.1 Antibody-drug Conjugates Industry Trends
11.4.2 Antibody-drug Conjugates Market Drivers
11.4.3 Antibody-drug Conjugates Market Challenges
11.4.4 Antibody-drug Conjugates Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antibody-drug Conjugates Distributors
12.3 Antibody-drug Conjugates Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock